Pharmacogenomics and Personalized Medicine
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.4 | Q3 | 39.9% | 0.730 | Q2 | 74.3% |
| 2024 | 1.8 | Q3 | 31.2% | 0.675 | Q2 | 72.4% |
| 2023 | 1.8 | Q3 | 33.8% | 0.508 | Q3 | 65.4% |
| 2022 | 1.9 | Q4 | 29.9% | 0.469 | Q3 | 64.3% |
| 2021 | 2.6 | Q3 | 45.6% | 0.683 | Q2 | 76.7% |
| 2020 | — | — | 0.845 | Q2 | 81.2% | |
| 2019 | — | — | 0.967 | Q1 | 84.9% | |
| 2018 | — | — | 0.965 | Q2 | 83.3% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
1178-7066
country
NZcoverage
2009-2026